IVC Stock Price
IVC RSI Chart
IVC Valuation
IVC Price/Sales (Trailing)
IVC Profitability
IVC Fundamentals
IVC Revenue
IVC Earnings
Price Action
Last 7 days
17.8%
Last 30 days
57.1%
Last 90 days
-9.1%
Trailing 12 Months
-70.7%
IVC Financial Health
IVC Investor Care
Peers (Alternatives to Invacare)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 106.2B | 18.4B | 6.78% | 4.67% | 45.05 | 5.76 | 7.84% | 18.25% |
MDT | 105.3B | 30.8B | -4.37% | -28.48% | 25.91 | 3.42 | -3.19% | -17.38% |
ISRG | 88.0B | 6.2B | 9.55% | -17.45% | 66.52 | 14.14 | 8.97% | -22.43% |
BDX | 69.5B | 19.0B | 4.93% | -5.45% | 43.13 | 3.66 | -0.43% | -8.78% |
EW | 49.6B | 5.4B | 1.40% | -30.34% | 32.6 | 9.22 | 2.86% | 1.25% |
| MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 12.57% | 9.89% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.6B | 847.1M | 6.58% | 27.77% | -5.3K | 12.46 | 13.32% | -137.89% |
GMED | 5.6B | 1.0B | -4.49% | -25.70% | 32.22 | 5.43 | 6.76% | 24.45% |
IRTC | 3.7B | 410.9M | 3.48% | -19.57% | -31.66 | 8.95 | 27.29% | -14.60% |
TNDM | 2.6B | 801.2M | 11.35% | -65.77% | -27.23 | 3.22 | 14.00% | -707.69% |
| SMALL-CAP | ||||||||
SILK | 1.5B | 138.6M | -26.53% | -5.16% | -27.14 | 10.77 | 36.62% | -10.44% |
AVNS | 1.3B | 820.0M | 2.39% | -14.54% | 26.48 | 1.63 | 10.13% | 701.59% |
BLFS | 887.4M | 154.8M | -10.66% | -9.26% | -8.53 | 5.73 | 60.29% | -2309.58% |
CSII | 833.4M | 239.8M | 0.76% | -10.38% | -22.01 | 3.47 | -4.74% | -31.15% |
Financials for Invacare
| Income Statement (Last 12 Months) | ||||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
| Revenue | -6.4% | 786,604,000 | 840,396,000 | 877,243,000 | 872,457,000 | 870,309,000 |
| Cost Of Revenue | -4.0% | 596,174,000 | 621,035,000 | 645,046,000 | 633,351,000 | 628,969,000 |
| Gross Profit | -13.2% | 190,430,000 | 219,361,000 | 232,197,000 | 239,106,000 | 241,340,000 |
| S&GA Expenses | -0.3% | 228,073,000 | 228,843,000 | 233,985,000 | 232,242,000 | 240,406,000 |
| R&D Expenses | - | 8,656,000 | - | - | - | - |
| EBITDA | -59.1% | -31,631,000 | -19,887,000 | -8,309,000 | 2,010,000 | -6,913,000 |
| EBITDA Margin | -69.9% | -0.04 | -0.02 | -0.01 | 0.00 | -0.01 |
| Earnings Before Taxes | -20.4% | -73,781,000 | -61,266,000 | -49,821,000 | -39,118,000 | -48,847,000 |
| EBT Margin | -28.7% | -0.09 | -0.07 | -0.06 | -0.04 | -0.06 |
| Interest Expenses | 4.3% | 26,044,000 | 24,974,000 | 24,828,000 | 24,307,000 | 25,466,000 |
| Net Income | -17.3% | -78,556,000 | -66,961,000 | -55,716,000 | -45,563,000 | -52,618,000 |
| Net Income Margin | -25.3% | -0.10 | -0.08 | -0.06 | -0.05 | -0.06 |
| Free Cahsflow | -86.3% | -30,961,000 | -16,616,000 | -43,958,000 | -32,007,000 | -35,607,000 |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
| Assets | -6.8% | 758 | 813 | 867 | 910 | 922 |
| Current Assets | -7.0% | 295 | 317 | 350 | 385 | 377 |
| Cash Equivalents | 3.5% | 45.00 | 44.00 | 52.00 | 84.00 | 74.00 |
| Inventory | -13.1% | 121 | 139 | 147 | 144 | 151 |
| Net PPE | -4.7% | 53.00 | 56.00 | 59.00 | 61.00 | 62.00 |
| Goodwill | -6.5% | 315 | 337 | 352 | 356 | 371 |
| Current Liabilities | -2.2% | 223 | 228 | 233 | 247 | 230 |
| Long Term Debt | - | 305 | - | - | - | - |
| LT Debt, Current | -0.5% | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 |
| LT Debt, Non Current | 6.9% | 333 | 311 | 309 | 305 | 306 |
| Shareholder's Equity | -45.1% | 81.00 | 148 | 189 | 218 | 240 |
| Retained Earnings | -146.2% | -57.85 | -23.49 | -1.55 | 23.00 | 21.00 |
| Additional Paid-In Capital | 0.8% | 281 | 279 | 277 | 277 | 278 |
| Shares Outstanding | 5.3% | 38.00 | 36.00 | 35.00 | 35.00 | - |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
| Cashflow From Operations | -368.3% | -24.36 | -5.20 | -28.25 | -14.31 | -15.73 |
| Share Based Compensation | 38.5% | -1.20 | -1.96 | -1.27 | 4.00 | 3.00 |
| Cashflow From Investing | 37.0% | -7.25 | -11.50 | -15.92 | -17.80 | -20.04 |
| Cashflow From Financing | 190.8% | 10.00 | -11.49 | 14.00 | 13.00 | 22.00 |
| Dividend Payments | NaN% | 0.00 | 0.00 | - | - | - |
| Buy Backs | 0% | 0.00 | 0.00 | 2.00 | 2.00 | - |
Risks for IVC
What is the probability of a big loss on IVC?
94.2%
Probability that Invacare stock will be more than 20% underwater in next one year
78.8%
Probability that Invacare stock will be more than 30% underwater in next one year.
75%
Probability that Invacare stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does IVC drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Invacare was unfortunately bought at previous high price.
Drawdowns
Returns for IVC
Cumulative Returns on IVC
-27.0%
10-Year Cumulative Returns
-35.9%
7-Year Cumulative Returns
-48.3%
5-Year Cumulative Returns
-55.9%
3-Year Cumulative Returns
What are the long-term rolling returns for IVC?
FIve years rolling returns for Invacare.
Annualized Returns
Which funds bought or sold IVC recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-06 | Rockefeller Capital Management L.P. | new | - | - | - | -% |
2023-02-15 | JANE STREET GROUP, LLC | new | - | 7,521 | 7,521 | -% |
2023-02-15 | Cerity Partners LLC | unchanged | - | -24,820 | 29,180 | -% |
2023-02-15 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | reduced | -39.06 | -14,000 | 7,000 | -% |
2023-02-15 | Virtu Financial LLC | sold off | -100 | -11,000 | - | -% |
2023-02-15 | Belvedere Trading LLC | new | - | 2,562 | 2,562 | -% |
2023-02-15 | NOMURA HOLDINGS INC | reduced | -11.93 | -258,000 | 200,000 | -% |
2023-02-14 | MILLENNIUM MANAGEMENT LLC | added | 131 | 8,000 | 41,000 | -% |
2023-02-14 | BNP PARIBAS ARBITRAGE, SNC | unchanged | - | -441 | 514 | -% |
2023-02-14 | NORTH RUN CAPITAL, LP | unchanged | - | -159,633 | 186,367 | 0.43% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Invacare News
Schedule 13G FIlings of Invacare
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | first manhattan co | 7.95% | 3e+06 | SC 13G | |
| Feb 13, 2023 | renaissance technologies llc | 4.03% | 1,521,569 | SC 13G/A | |
| Feb 03, 2023 | charles schwab investment management inc | 9.47% | 3,575,752 | SC 13G | |
| Nov 22, 2022 | rosen steven h | 9.7% | 3,665,233 | SC 13D/A | |
| Aug 25, 2022 | rosen steven h | 10.3% | 3,946,558 | SC 13D/A | |
| Jul 08, 2022 | blackrock inc. | 2.1% | 763,799 | SC 13G | |
| Jun 07, 2022 | rosen steven h | 10.7% | 3,796,558 | SC 13D/A | |
| May 02, 2022 | rosen steven h | 9.2% | 3,221,558 | SC 13D | |
| Feb 14, 2022 | pura vida investments, llc | 0% | 0 | SC 13G/A | |
| Feb 11, 2022 | renaissance technologies llc | 5.26% | 1,841,441 | SC 13G/A |
IVC Fair Value
Invacare fair value in different scenarios
The table shows the Fair Value estimates for Invacare for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 0.80 - | 1.26 - | 2.34 - | 3.65 - | 5.31 - |
| Current Inflation | 0.77 - | 1.20 - | 2.21 - | 3.44 - | 4.98 - |
| Very High Inflation | 0.73 - | 1.13 - | 2.05 - | 3.17 - | 4.55 - |
Historical Invacare Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Invacare
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 16, 2023 | 25-NSE | 25-NSE | |
| Feb 14, 2023 | SC 13G | Major Ownership Report | |
| Feb 13, 2023 | SC 13G/A | Major Ownership Report | |
| Feb 03, 2023 | SC 13G | Major Ownership Report | |
| Feb 03, 2023 | 8-K | Current Report | |
| Feb 01, 2023 | 8-K | Current Report | |
| Jan 31, 2023 | 8-K | Current Report | |
| Dec 27, 2022 | 8-K | Current Report |
Latest Insider Trading transactions for IVC
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-02-20 | Purtill Geoffrey | back to issuer | - | - | -1,666 | president and ceo |
2022-11-21 | CRAWFORD EDWARD F | back to issuer | - | - | -24,671 | - |
2022-11-21 | Rosen Steven H | back to issuer | - | - | -24,671 | - |
2022-11-18 | Rosen Steven H | sold | -39,174 | 0.381 | -102,820 | - |
2022-11-17 | Rosen Steven H | sold | -9,060 | 0.453 | -20,000 | - |
2022-11-16 | Rosen Steven H | sold | -9,720 | 0.486 | -20,000 | - |
2022-11-15 | Rosen Steven H | sold | -38,700 | 0.496 | -78,025 | - |
2022-11-14 | Rosen Steven H | sold | -30,361 | 0.502 | -60,480 | - |
2022-09-13 | Purtill Geoffrey | acquired | - | - | 100,000 | president and ceo |
2022-09-13 | MERRIMAN MICHAEL J | acquired | - | - | 154,852 | - |
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
IVC Income Statement
2022-09-30Condensed Consolidated Statement of Comprehensive Income (Loss) - USD ($) shares in Thousands | 3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |||
| Statement of Comprehensive Income [Abstract] | ||||||
| Net Sales | $ 170,408,000 | $ 224,200,000 | $ 560,413,000 | $ 646,266,000 | ||
| Cost of products sold | 139,029,000 | 163,890,000 | 433,323,000 | 470,500,000 | ||
| Gross Profit | 31,379,000 | 60,310,000 | 127,090,000 | 175,766,000 | ||
| Selling, general and administrative expenses | 55,365,000 | 56,135,000 | 174,552,000 | 178,721,000 | ||
| Charges related to restructuring activities | 8,440,000 | 377,000 | 16,383,000 | 2,476,000 | ||
| Impairment of Intangible Assets (Excluding Goodwill) | 1,012,000 | 0 | 1,012,000 | 0 | ||
| Goodwill, Impairment Loss | 0 | 28,564,000 | 0 | 28,564,000 | ||
| Operating Loss | (33,438,000) | (24,766,000) | (64,857,000) | (33,995,000) | ||
| Net gain on convertible debt derivatives | (950,000) | 0 | (950,000) | 0 | ||
| Net gain on debt extinguishment | (6,398,000) | (10,131,000) | (6,398,000) | (9,422,000) | ||
| Interest expense | 7,354,000 | 6,284,000 | 19,836,000 | 18,099,000 | ||
| Interest Income, Other | 10,000 | 0 | 11,000 | 1,000 | ||
| Loss Before Income Taxes | (33,434,000) | (20,919,000) | (77,334,000) | (42,671,000) | ||
| Income tax provision | 920,000 | 1,840,000 | 3,160,000 | 4,830,000 | ||
| Net Loss | $ (34,354,000) | $ (22,759,000) | $ (80,494,000) | $ (47,501,000) | ||
| Net Loss per Share—Basic | ||||||
| Net Loss per Share—Basic | $ (0.92) | $ (0.65) | $ (2.23) | $ (1.36) | ||
| Weighted Average Shares Outstanding—Basic | 37,537 | 35,013 | 36,073 | 34,826 | ||
| Loss per Share—Assuming Dilution | ||||||
| Loss per Share—Assuming Dilution | [1] | $ (0.92) | $ (0.65) | $ (2.23) | $ (1.36) | |
| Weighted Average Shares Outstanding—Assuming Dilution | 37,680 | 35,488 | 36,241 | 35,371 | ||
| Other comprehensive income (loss): | ||||||
| Foreign currency translation adjustments | $ (34,051,000) | $ (19,202,000) | $ (66,938,000) | $ (6,487,000) | ||
| Defined Benefit Plans: | ||||||
| Amortization of prior service costs and unrecognized losses | 45,000 | (27,000) | 4,608,000 | (422,000) | ||
| Deferred tax adjustment resulting from defined benefit plan activity | (9,000) | 20,000 | (94,000) | (43,000) | ||
| Valuation reserve associated with defined benefit plan activity | 9,000 | (20,000) | 94,000 | 43,000 | ||
| Current period gain (loss) on cash flow hedges | (1,394,000) | 1,423,000 | 298,000 | 649,000 | ||
| Deferred tax benefit (provision) related to gain on cash flow hedges | 178,000 | (170,000) | (62,000) | (73,000) | ||
| Other Comprehensive Loss | (35,222,000) | (17,976,000) | (62,094,000) | (6,333,000) | ||
| Comprehensive Loss | $ (69,576,000) | $ (40,735,000) | $ (142,588,000) | $ (53,834,000) | ||
| ||||||
IVC Balance Sheet
2022-09-30Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2022 | Jun. 30, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash and cash equivalents | $ 45,439 | $ 83,745 | ||||
| Trade receivables, net | 80,105 | 117,115 | ||||
| Installment receivables, net | 255 | 218 | ||||
| Inventories, net | 120,687 | 144,274 | ||||
| Other current assets | 48,338 | 40,036 | ||||
| Total Current Assets | 294,824 | 385,388 | ||||
| Other Assets | 5,330 | 5,362 | ||||
| Intangibles, net | 23,390 | 26,356 | ||||
| Property and Equipment, net | 53,244 | 60,921 | ||||
| Finance Lease, Right-of-Use Asset | 56,083 | 63,029 | ||||
| Operating Lease, Right-of-Use Asset | 9,980 | 12,600 | ||||
| Goodwill | 314,755 | 355,875 | ||||
| Total Assets | 757,606 | 909,531 | ||||
| Current Liabilities | ||||||
| Accounts payable | 95,973 | 130,036 | ||||
| Accrued expenses | 116,330 | 102,971 | ||||
| Current taxes payable | 2,136 | 3,914 | ||||
| Current portion of long-term debt | 2,150 | 3,107 | ||||
| Current portion of finance lease obligations | 3,031 | 3,009 | ||||
| Current portion of operating lease obligations | 3,062 | 4,217 | ||||
| Total Current Liabilities | 222,682 | 247,254 | ||||
| Long-Term Debt | 333,129 | 305,022 | ||||
| Finance Lease Long-Term Obligations | 57,511 | 63,736 | ||||
| Operating Leases Long-Term Obligations | 6,865 | 8,234 | ||||
| Other Long-Term Obligations | 56,374 | 66,796 | ||||
| Shareholders’ Equity | ||||||
| Preferred Shares (Authorized 300 shares; none outstanding) | 0 | 0 | ||||
| Additional paid-in-capital | 281,130 | 276,665 | ||||
| Retained earnings (accumulated deficit) | (57,849) | 22,645 | ||||
| Accumulated other comprehensive income (loss) | (45,106) | $ (9,884) | 16,988 | $ 39,103 | $ 57,079 | $ 45,436 |
| Treasury Shares (4,535 and 4,397 shares at September 30, 2022 and December 31, 2021, respectively) | (107,939) | (107,788) | ||||
| Total Shareholders’ Equity | 81,045 | $ 147,604 | 218,489 | $ 239,714 | $ 280,890 | $ 333,846 |
| Total Liabilities and Shareholders’ Equity | 757,606 | 909,531 | ||||
| Common Shares [Member] | ||||||
| Shareholders’ Equity | ||||||
| Common Shares | 10,807 | 9,977 | ||||
| Class B Common Shares [Member] | ||||||
| Shareholders’ Equity | ||||||
| Common Shares | $ 2 | $ 2 |